FDA approves first interchangeable biosimilars to Eylea to treat macular degeneration and other eye conditionsFDA approves first interchangeable biosimilars to Eylea to treat macular degeneration and other eye conditions

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-eylea-treat-macular-degeneration-and-other-eye?utm_medium=email&utm_source=govdelivery